The Effect of Different Doses of Botulinum Toxin on Masseter Muscle in Patients with Bruxism.
Background and Objectives: Botulinum toxin type A is produced by clostridium botulinum. It acts by inhibiting the release of acetylcholine from cholinergic neurons. Botulinum toxin has been used for management of bruxism, which is a parafunctional disorder and characterized by clenching or grinding...
Saved in:
Main Authors: | Kawa F. Dizaye, Sarezh Jamal Jalal |
---|---|
Format: | Article |
Language: | English |
Published: |
College Of Dentistry Hawler Medical University
2022-02-01
|
Series: | Erbil Dental Journal |
Subjects: | |
Online Access: | https://edj.hmu.edu.krd/index.php/journal/article/view/139 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wearable Regionally Trained AI-Enabled Bruxism-Detection System
by: Anusha Ishtiaq, et al.
Published: (2025-01-01) -
Patient-centred evaluation of a reduced dose of botulinum toxin A in the management of myofascial pain
by: Alice Cameron, et al.
Published: (2025-03-01) -
Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort
by: Gabrielle French, et al.
Published: (2020-01-01) -
SURFACE ELECTROMYOGRAPHY ASSESSMENT OF MASTICATORY MUSCLES RESPONSE TO CLEAR ALIGNER THERAPY: AN OBJECTIVE PRISMA STANDARDIZED SYSTEMATIC REVIEW
by: Amelia Anita Andreica, et al.
Published: (2024-12-01) -
Iatrogenic Botulism After Cosmetic Use of Botulinum Toxin‐A: A Case Series
by: Mohammad Asadi, et al.
Published: (2025-01-01)